The study included nearly 2 million patients, making it the largest ever conducted on this group of glucagon-like peptide-1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback